Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Expression of serine and glycine-related enzymes in phyllodes tumor.

Kwon JE, Kim DH, Jung WH, Koo JS.

Neoplasma. 2014;61(5):566-78. doi: 10.4149/neo_2014_069.

PMID:
25030440
2.

Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype.

Sun WY, Kim HM, Jung WH, Koo JS.

J Transl Med. 2016 Jun 8;14(1):168. doi: 10.1186/s12967-016-0915-8.

3.

Expression levels of serine/glycine metabolism-related proteins in triple negative breast cancer tissues.

Noh S, Kim DH, Jung WH, Koo JS.

Tumour Biol. 2014 May;35(5):4457-68. doi: 10.1007/s13277-013-1588-z.

PMID:
24390667
4.

Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes.

Kim SK, Jung WH, Koo JS.

PLoS One. 2014 Jun 30;9(6):e101004. doi: 10.1371/journal.pone.0101004.

5.

E-cadherin expression in the epithelial components of mammary phyllodes tumors.

Tsang JY, Mendoza P, Putti TC, Karim RZ, Scolyer RA, Lee CS, Pang AL, Tse GM.

Hum Pathol. 2012 Dec;43(12):2117-23. doi: 10.1016/j.humpath.2012.03.028.

PMID:
22820000
6.
7.

The expression of glutamine-metabolism-related proteins in breast phyllodes tumors.

Kim S, Jung WH, Koo JS.

Tumour Biol. 2013 Oct;34(5):2683-9. doi: 10.1007/s13277-013-0819-7.

PMID:
23636801
8.

Expression of Yes-associated protein (YAP) in breast phyllodes tumor.

Kim SK, Jung WH, Koo JS.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):5997-6005.

9.

p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome.

Feakins RM, Mulcahy HE, Nickols CD, Wells CA.

Histopathology. 1999 Aug;35(2):162-9.

PMID:
10460662
10.
11.

Expression of metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.

Kim YH, Jung WH, Koo JS.

Tumour Biol. 2014 Oct;35(10):10381-93. doi: 10.1007/s13277-014-2345-7.

PMID:
25053597
12.

p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.

Tan PH, Jayabaskar T, Yip G, Tan Y, Hilmy M, Selvarajan S, Bay BH.

Mod Pathol. 2005 Dec;18(12):1527-34.

13.

The expression of succinate dehydrogenase in breast phyllodes tumor.

Choi J, Kim DH, Jung W, Koo JS.

Histol Histopathol. 2014 Oct;29(10):1343-54. doi: 10.14670/HH-29.1343.

PMID:
24807638
14.

Site-specific metabolic phenotypes in metastatic breast cancer.

Kim HM, Jung WH, Koo JS.

J Transl Med. 2014 Dec 14;12:354. doi: 10.1186/s12967-014-0354-3.

15.
16.

Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors.

Kuijper A, de Vos RA, Lagendijk JH, van der Wall E, van Diest PJ.

Am J Clin Pathol. 2005 May;123(5):690-8.

PMID:
15981808
17.

Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast.

Feakins RM, Wells CA, Young KA, Sheaff MT.

Hum Pathol. 2000 Oct;31(10):1214-22.

PMID:
11070114
18.

Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours.

Tse GM, Chaiwun B, Lau KM, Scolyer R, Lee CS, Karim RZ, Putti TC, Law BK, Lui PC, Tan PH.

J Clin Pathol. 2007 Sep;60(9):1051-6.

19.
20.

Analysis of phyllodes tumor recurrence according to the histologic grade.

Kim S, Kim JY, Kim DH, Jung WH, Koo JS.

Breast Cancer Res Treat. 2013 Oct;141(3):353-63. doi: 10.1007/s10549-013-2684-x.

PMID:
24062207
Items per page

Supplemental Content

Support Center